Primer: Regent Pacific (575 HK) - Aug 2026
Regent Pacific is transitioning to a commercial-stage biopharmaceutical company, with the recent approval of its premature ejaculation...
99 Views
No more insights
𝛼SK or SearchENTITY
Regent Pacific (575 HK)
Regent Pacific (575 HK)
2
Analysis
Health Care • Hong Kong
Regent Pacific is an investment holding company focused on the healthcare and life sciences sectors. It engages in the research, development, manufacturing, marketing, and sale of pharmaceutical products for urological disorders, such as Fortacin™/Senstend™, and develops AI systems for biological aging clocks through Deep Longevity. The company was founded in 1991 and is headquartered in Central, Hong Kong.
morex